Does DAPAGLIFLOZIN Cause Pulmonary embolism? 170 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 170 reports of Pulmonary embolism have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 0.8% of all adverse event reports for DAPAGLIFLOZIN.
170
Reports of Pulmonary embolism with DAPAGLIFLOZIN
0.8%
of all DAPAGLIFLOZIN reports
10
Deaths
34
Hospitalizations
How Dangerous Is Pulmonary embolism From DAPAGLIFLOZIN?
Of the 170 reports, 10 (5.9%) resulted in death, 34 (20.0%) required hospitalization, and 11 (6.5%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 170 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN Cause?
Death (2,775)
Diabetic ketoacidosis (1,773)
Acute kidney injury (982)
Off label use (891)
Nausea (884)
Dehydration (860)
Vomiting (838)
Dizziness (817)
Ketoacidosis (803)
Fatigue (785)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which DAPAGLIFLOZIN Alternatives Have Lower Pulmonary embolism Risk?
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN vs DAPRODUSTAT
DAPAGLIFLOZIN vs DAPSONE
DAPAGLIFLOZIN vs DAPTOMYCIN